Cargando…
Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
TERT promoter (TERTp) mutations are important factors in papillary thyroid carcinomas (PTCs). They are associated with tumor aggressiveness, recurrence, and disease-specific mortality and their use in risk stratification of PTC patients has been proposed. In this study we investigated the prevalence...
Autores principales: | Rusinek, Dagmara, Pfeifer, Aleksandra, Krajewska, Jolanta, Oczko-Wojciechowska, Malgorzata, Handkiewicz-Junak, Daria, Pawlaczek, Agnieszka, Zebracka-Gala, Jadwiga, Kowalska, Malgorzata, Cyplinska, Renata, Zembala-Nozynska, Ewa, Chekan, Mykola, Chmielik, Ewa, Kropinska, Aleksandra, Lamch, Roman, Jurecka-Lubieniecka, Beata, Jarzab, Barbara, Czarniecka, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163174/ https://www.ncbi.nlm.nih.gov/pubmed/30200646 http://dx.doi.org/10.3390/ijms19092647 |
Ejemplares similares
-
TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2020) -
The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAF(V600E) Mutation Status and Other Prognostic Factors
por: Czarniecka, Agnieszka, et al.
Publicado: (2015) -
Novel TG‐FGFR1 and TRIM33‐NTRK1 transcript fusions in papillary thyroid carcinoma
por: Pfeifer, Aleksandra, et al.
Publicado: (2019) -
Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
por: Rusinek, Dagmara, et al.
Publicado: (2017) -
Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma—Do They Exist?
por: Szpak-Ulczok, Sylwia, et al.
Publicado: (2020)